Author

Iria Bastón-Rey

SAFETY OF INFLAMMATORY BOWEL DISEASE TREATMENTS IN PATIENTS WITH SOLID ORGAN TRANSPLANTATION (EITOS STUDY OF GETECCU)
SAFETY OF INFLAMMATORY BOWEL DISEASE TREATMENTS IN PATIENTS WITH SOLID ORGAN TRANSPLANTATION (EITOS STUDY OF GETECCU)

Iria Bastón-Rey  et al.

INFLUENCE OF THE INTERVAL OF TIME BETWEEN ANTI-TNF AND VEDOLIZUMAB OR USTEKINUMAB IN THE RESPONSE TO TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
INFLUENCE OF THE INTERVAL OF TIME BETWEEN ANTI-TNF AND VEDOLIZUMAB OR USTEKINUMAB IN THE RESPONSE TO TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Iria Bastón-Rey  et al.

INFLAMMATORY BOWEL DISEASE AND SOLID ORGAN TRANSPLANTATION. NATURAL HISTORY OF PRE-EXISTING AND DE NOVO IBD PATIENTS. (EITOS STUDY OF GETECCU)
INFLAMMATORY BOWEL DISEASE AND SOLID ORGAN TRANSPLANTATION. NATURAL HISTORY OF PRE-EXISTING AND DE NOVO IBD PATIENTS. (EITOS STUDY OF GETECCU)

Iria Bastón-Rey

SAFETY OF INFLAMMATORY BOWEL DISEASE TREATMENTS IN PATIENTS WITH SOLID ORGAN TRANSPLANTATION (EITOS STUDY OF GETECCU)
SAFETY OF INFLAMMATORY BOWEL DISEASE TREATMENTS IN PATIENTS WITH SOLID ORGAN TRANSPLANTATION (EITOS STUDY OF GETECCU)

RELATIONSHIP BETWEEN INTESTINAL ULTRASOUND, FECAL CALPROTECTIN AND HARVEY BRADSHAW INDEX IN THE ASSESSMENT OF INFLAMMATORY ACTIVITY IN CROHN'S DISEASE
RELATIONSHIP BETWEEN INTESTINAL ULTRASOUND, FECAL CALPROTECTIN AND HARVEY BRADSHAW INDEX IN THE ASSESSMENT OF INFLAMMATORY ACTIVITY IN CROHN'S DISEASE

Iria Bastón-Rey  et al.

EFFECTIVENESS AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY
EFFECTIVENESS AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY

Iria Bastón-Rey  et al.

OPEN LABEL, RANDOMIZED, CROSSOVER CLINICAL TRIAL TO ASSESS THE EFFICACY OF INCREASING DOSES OF PANCREATIC ENZYMES, WITH OR WITHOUT INHIBITION OF GASTRIC ACID SECRETION, IN PATIENTS WITH PANCREATIC EXOCRINE INSUFFICIENCY SECONDARY TO CHRONIC PANCREATITIS
OPEN LABEL, RANDOMIZED, CROSSOVER CLINICAL TRIAL TO ASSESS THE EFFICACY OF INCREASING DOSES OF PANCREATIC ENZYMES, WITH OR WITHOUT INHIBITION OF GASTRIC ACID SECRETION, IN PATIENTS WITH PANCREATIC EXOCRINE INSUFFICIENCY SECONDARY TO CHRONIC PANCREATITIS

Iria Bastón-Rey  et al.

LONG-TERM DURABILITY AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY
LONG-TERM DURABILITY AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY

Iria Bastón-Rey  et al.

UNCONTROLLED DEPRESSION AND FEMALE GENDER INCREASES THE RISK OF SEVERE FATIGUE MORE THAN ACTIVITY DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER INFLIXIMAB THERAPY
UNCONTROLLED DEPRESSION AND FEMALE GENDER INCREASES THE RISK OF SEVERE FATIGUE MORE THAN ACTIVITY DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER INFLIXIMAB THERAPY

Iria Bastón-Rey  et al.

IMPACT OF BIOLOGICAL AGENTS ON POSTOPERATIVE COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE STUDY OF GETECCU
IMPACT OF BIOLOGICAL AGENTS ON POSTOPERATIVE COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE STUDY OF GETECCU

Iria Bastón-Rey  et al.

DO PSEUDOPOLYPS INCREASE FECAL CALPROTECTIN IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION?
DO PSEUDOPOLYPS INCREASE FECAL CALPROTECTIN IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION?

Iria Bastón-Rey  et al.

THE INFLUENCE OF PREOPERATIVE MEDICATIONS IN SURGICAL COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE IN SPAIN: A MULTICENTER STUDY OF GETECCU
THE INFLUENCE OF PREOPERATIVE MEDICATIONS IN SURGICAL COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE IN SPAIN: A MULTICENTER STUDY OF GETECCU

Iria Bastón-Rey  et al.

PROTEOMIC AND LIPIDOMIC ANALYSIS REVEAL ALTERATIONS OF COMPLEMENT ACTIVATION AND LIPID METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
PROTEOMIC AND LIPIDOMIC ANALYSIS REVEAL ALTERATIONS OF COMPLEMENT ACTIVATION AND LIPID METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Iria Bastón-Rey  et al.

PREDICTIVE TRANSCRIPTIONAL SIGNATURES ASSOCIATED TO VEDOLIZUMAB THERAPY RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS
PREDICTIVE TRANSCRIPTIONAL SIGNATURES ASSOCIATED TO VEDOLIZUMAB THERAPY RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS

Iria Bastón-Rey  et al.

THE JAK-3 AND TYK-2 / STAT PATHWAYS ARE ACTIVATED IN MODERATE TO SEVERE ULCERATIVE COLITIS
THE JAK-3 AND TYK-2 / STAT PATHWAYS ARE ACTIVATED IN MODERATE TO SEVERE ULCERATIVE COLITIS

Iria Bastón-Rey  et al.

JAK/STAT PATHWAY AND IL-6 ACTIVITY IN MODERATE TO SEVERE ULCERATIVE COLITIS
JAK/STAT PATHWAY AND IL-6 ACTIVITY IN MODERATE TO SEVERE ULCERATIVE COLITIS

Iria Bastón-Rey  et al.

MICROBIOME CHARACTERIZATION IN STOOL FROM NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
MICROBIOME CHARACTERIZATION IN STOOL FROM NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Iria Bastón-Rey  et al.

URINARY METABOLOME IN NEWLY DIAGNOSED TREATMENT-NAÏVE CROHN’S DISEASE PATIENTS: RESULTS FROM THE IBDOMICS STUDY
URINARY METABOLOME IN NEWLY DIAGNOSED TREATMENT-NAÏVE CROHN’S DISEASE PATIENTS: RESULTS FROM THE IBDOMICS STUDY

Iria Bastón-Rey  et al.

PROTEOMIC PROFILE OF SERUM AND URINE IN NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: NEW APPROACH FOR BIOMARKER DISCOVERY
PROTEOMIC PROFILE OF SERUM AND URINE IN NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: NEW APPROACH FOR BIOMARKER DISCOVERY

Iria Bastón-Rey  et al.

IDENTIFICATION OF URINE AND SERUM DIAGNOSTIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE USING A PROTEOMIC APPROACH
IDENTIFICATION OF URINE AND SERUM DIAGNOSTIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE USING A PROTEOMIC APPROACH

Iria Bastón-Rey  et al.

Item 1 - 20 / 22
1
2